SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CUNEO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.829
EU - Europa 6.429
AS - Asia 5.086
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 13
SA - Sud America 13
AF - Africa 4
Totale 34.387
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.814
CN - Cina 2.588
UA - Ucraina 1.656
DE - Germania 1.312
TR - Turchia 1.169
IT - Italia 1.082
SG - Singapore 893
GB - Regno Unito 652
SE - Svezia 400
FI - Finlandia 396
PL - Polonia 362
FR - Francia 228
ID - Indonesia 190
VN - Vietnam 134
RU - Federazione Russa 132
CZ - Repubblica Ceca 68
BE - Belgio 60
HK - Hong Kong 39
IN - India 29
NL - Olanda 22
ES - Italia 12
IR - Iran 12
AU - Australia 11
EU - Europa 10
IE - Irlanda 10
BR - Brasile 9
JP - Giappone 9
RO - Romania 9
CA - Canada 8
AT - Austria 7
CH - Svizzera 6
KR - Corea 6
IL - Israele 5
MX - Messico 5
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
MK - Macedonia 3
BD - Bangladesh 2
BG - Bulgaria 2
BY - Bielorussia 2
CL - Cile 2
HU - Ungheria 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PH - Filippine 2
EE - Estonia 1
GT - Guatemala 1
HR - Croazia 1
LT - Lituania 1
MA - Marocco 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
SI - Slovenia 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 34.387
Salva come PNG Salva come JPEG
Città #
Fairfield 3.015
Woodbridge 2.968
Houston 1.998
Jacksonville 1.857
Chandler 1.676
Ann Arbor 1.362
Ashburn 1.323
Seattle 1.156
Wilmington 1.125
Cambridge 976
Singapore 651
Izmir 643
Nanjing 592
Beijing 567
Princeton 480
Warsaw 354
San Diego 311
Boardman 307
Ferrara 268
New York 225
Milan 206
Shanghai 200
Jakarta 189
Shenyang 188
Nanchang 171
Dong Ket 132
Hebei 128
Bremen 115
Addison 113
Santa Clara 103
Changsha 97
Los Angeles 96
Tianjin 93
Falls Church 88
Jiaxing 87
Dearborn 83
Jinan 70
Mountain View 69
Redwood City 63
Zhengzhou 61
Brussels 57
Norwalk 55
London 53
Brno 47
San Mateo 46
Kunming 45
Ningbo 40
Hong Kong 37
Guangzhou 34
Orange 34
Munich 31
Des Moines 28
Washington 28
Auburn Hills 27
Rome 27
Helsinki 26
Taizhou 25
Tappahannock 25
Verona 24
Augusta 22
Chicago 21
Hangzhou 21
Indiana 21
Lappeenranta 21
Changchun 20
Bologna 19
Olomouc 19
Philadelphia 18
Haikou 17
Lanzhou 17
Florence 16
Leawood 16
San Francisco 16
Redmond 15
Napoli 14
Hefei 13
San Jose 13
Parma 12
Kilburn 11
Lozzo Atestino 11
Prineville 10
Springfield 10
Bari 9
Amsterdam 8
Fuzhou 8
Monmouth Junction 8
Dublin 7
Hounslow 7
Modena 7
Mumbai 7
Voghera 7
Chiswick 6
Monza 6
Wuhan 6
Fort Worth 5
Naples 5
Newark 5
Saint Louis 5
Siena 5
Taiyuan 5
Totale 25.384
Salva come PNG Salva come JPEG
Nome #
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 191
Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation 188
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 182
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia. 176
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 168
CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis 168
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 161
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 161
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 158
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 158
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 154
The active metabolite of warfarin (3′-hydroxywarfarin) and correlation with INR, warfarin and drug weekly dosage in patients under oral anticoagulant therapy: A pharmacogenetics study 153
MORFOLOGIA E FISIOPATOLOGIA DEL SANGUE E DEGLI ORGANI EMOPOIETICI 149
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 149
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 146
Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML 142
5' region and exon 7 mutations of the TP53 gene in two cases of B-cell prolymphocytic leukemia. 140
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 140
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 138
Novel small deletions of the p53 gene in late stage B-cell chronic lymphocytic leukaemia 136
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 136
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype 135
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 134
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 133
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 132
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 131
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 131
Acute Human Herpesvirus-6A infection of human mesothelial cells modulates HLA molecules 131
Secondary chromosome changes in mantle cell lymphoma: cytogenetic and fluorescence in situ hybridization studies. 130
Ibrutinib in the real world patient: Many lights and some shades 130
Tryptase-positive mast cells predict clinical outcome of patients with early B-cell chronic lymphocytic leukemia 130
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 129
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 128
Minimal morphological criteria for defining bone marrow dysplasia: A basis for clinical implementation of WHO classification of myelodysplastic syndromes 128
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 127
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells 127
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 127
A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs 126
null 124
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 124
Waldenstrom macroglobulinemia 124
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 124
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 123
Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings. 123
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia. 122
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 122
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype 122
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 122
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 122
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 121
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 120
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib 119
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 119
Exercise training and endothelial progenitor cells in haemodialysis patients 118
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 118
null 118
A novel translocation t(1;7)(p36;q34) in three patients with acute myeloid leukaemia 117
Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: Comparison with metaphase banding analysis 116
Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome on behalf of the GIMEMA chronic lymphoproliferative diseases working group 116
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 114
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 114
Hepatosplenic T-cell lymphoma (HSTCL). 113
Dendritic cells in acute promyelocytic leukaemia 113
Cytogenetic and clinicobiological features of acute leukemia with stem cell phenotype: study of nine cases 113
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 113
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 113
Delirium in acute promyelocytic leukemia patients: two case reports. 113
Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: Cytologic and cytogenetic evidence in thirty-four patients 112
A prospective survey of febrile events in hematological malignancies 112
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells. 111
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 111
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia. 110
Etiology of Febrile Episodes in Patients With Acute Myeloid Leukemia: Results From the Hema e-Chart Registry 110
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 110
A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma 110
Myelofibrosis with Myeloid Metaplasia (MMM)/Idiopathic myelofibrosis/Agnogenic myeloid metaplasia 110
Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation 109
An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients 109
Distinct cytogenetic and clinicopathologic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents. 109
Minor myeloid component in Ph chromosome-positive acute lymphoblastic leukaemia: correlation with cytogenetic pattern and implication for poor response to therapy 108
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 108
[Use of 5-phosphodiesterase inhibitors in patients with LUTS secondary to BPH: our experience and review of the literature]. 108
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 108
Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol 107
Trisomy 8 in PDGFRB-negative cells in a patient with imatinib-sensitive chronic myelomonocytic leukemia and t(5;16)(q33;p13) PDGFRB-NDE1 fusion 107
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 107
Special cytological subtypes of acute myeloid leukaemias and myelodysplastic syndromes 107
Early CP CML, Nilotinib 400 mg Twice Daily Frontline: Beyond 3 Years, Results Remain Excellent and Stable (A GIMEMA CML Working Party Trial) 107
null 106
Cytogenetics in myelodysplastic syndromes: Old methods, new clues 106
null 105
t(4;11)(q21;p15) translocation involving NUP98 and RAP1GDS1 genes: characterization of a new subset of T acute lymphoblastic leukaemia 105
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis. 105
Therapy-related adult acute lymphoblastic leukemia with t(4;11)(q21;q23): MLL rearrangement, p53 mutation and multilineage involvement 105
Increased serum levels of matrix metalloproteinase-9 predict clinical outcome of patients with early B-cell chronic lymphocytic leukaemia. 104
Angiopoietin-2 Plasma Dosage Predicts Time to First Treatment (TTFT) and Overall Survival (OS) in Chronic Lymphocytic Leukemia. 104
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics. 104
Merkel-cell polyomavirus (MCPyV) is rarely associated to B-chronic lymphocytic leukemia (1 out of 50) samples and occurs late in the natural history of the disease 104
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 103
Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features 103
Totale 12.487
Salva come PNG Salva come JPEG
Categoria #
all - tutte 166.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 19.347
Totale 185.471
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.811 0 0 197 1.062 481 843 631 748 574 810 333 132
2020/20215.638 418 469 311 546 275 620 206 639 109 802 779 464
2021/20224.235 230 531 203 195 226 230 230 260 138 359 427 1.206
2022/20234.073 500 178 138 464 698 594 181 363 560 21 250 126
2023/20242.042 186 284 97 50 128 283 89 111 65 55 79 615
2024/20251.297 315 200 782 0 0 0 0 0 0 0 0 0
Totale 35.080